English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

Pirtobrutinib matches or exceeds efficacy versus ibrutinib in CLL/SLL head-to-head trial

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

Kiwifruit consumption raises vitamin C levels in human skin but shows limited effect on collagen

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

Epcoritamab combined with standard therapy improves survival in relapsed follicular lymphoma

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

Chemotherapy-only regimen shows similar success as irradiation before B-ALL transplant

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

Virtual diet and exercise program may help lymphoma patients manage treatment side effects

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

GSK ends cancer research partnership with Ideaya Biosciences after five years

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

ASH meeting highlights new CAR-T advances and updates on sickle cell disease treatments

+ Pharmaceuticals
Patient Daily | Dec 8, 2025

Tulane study finds ablation reduces risks for patients with AFib and sleep apnea

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily